SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Tetratherix provides FDA review update on Tegenix 510(K)

Tetratherix Ltd. announced it received a substantive update regarding its Tegenix 510(K) submission from the U.S. Food and Drug Administration.

TTX